Bridging the Evidence Gap in Male Infertility: Real-World Prescribing Patterns of Clomiphene Citrate and the Disconnect Between Surrogate and Clinical Outcomes
Preprint
- 8 June 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: Clomiphene citrate (CC) is widely used off-label for male infertility despite limited evidence and inconsistent guideline recommendations. Although previous studies suggest variability in clinical practice, real-world data on prescribing patterns, patient selection, monitoring, and treatment success definitions remain limited. This study assessed CC prescribing patterns among urologists and identified factors associated with its use. Methods: A national, cross-sectional, web-based survey was conducted among urologists in Türkiye between November and December 2025. Of 1,558 invited participants, 421 responded (27.0%), and 402 were included in the final analysis. The questionnaire was based on European Association of Urology and American Urological Association guidelines, refined through expert consensus, and pilot-tested. Multivariable logistic regression identified independent predictors of CC use. Results: CC was used by 39.3% of respondents and was independently associated with private practice (odds ratio [OR] = 2.90, p < 0.001), greater professional experience (OR = 2.18, p = 0.002), and higher infertility case volume (OR = 2.27, p = 0.001). Substantial heterogeneity was observed in patient selection, dosing, monitoring, and success definitions. Treatment goals mainly focused on surrogate laboratory outcomes, including semen parameters and testosterone levels, rather than pregnancy and live birth. An indication paradox was identified for hypogonadotropic hypogonadism, and 31.6% of clinicians reported not routinely providing risk counseling. Conclusions: CC prescribing for male infertility remains heterogeneous and mainly driven by clinician experience rather than standardized protocols. The reliance on surrogate outcomes highlights a gap between evidence and practice, emphasizing the need for standardized frameworks and clearer guidance on patient selection, monitoring, and counseling.Keywords
All Related Versions
- Version 1, 2026-06-08, Preprints
- Published version: Journal of Clinical Medicine, 15 (13), 5014.
This publication has 39 references indexed in Scilit:
- European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male InfertilityEuropean Urology, 2025
- Efficacy of clomiphene citrate and tamoxifen on pregnancy rates in idiopathic male subfertility: A systematic review and meta-analysisAsian Journal of Urology, 2024
- APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular functionReproductive BioMedicine Online, 2023
- Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysisEuropean Urology, 2019
- National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologiesFertility and Sterility, 2018
- A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional StudyJournal of Urology, 2017
- Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce SurveyFertility and Sterility, 2016
- Bone Mineral Density and Response to Treatment in Men Younger Than 50 Years with Testosterone Deficiency and Sexual Dysfunction or InfertilityJournal of Urology, 2014
- Empirical Medical Therapy for Idiopathic Male Infertility: A Survey of the American Urological AssociationJournal of Urology, 2012
- Visual Disturbance Secondary to Clomiphene CitrateArchives of Ophthalmology (1950), 1995